Peter Novodvorsky

9PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityElectrical energy generation (incl. renewables, excl. photovoltaics)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 15, 2025
Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.

Peter Novodvorský, Lenka Thieme, Ivana Laňková

|Feb 28, 2025
Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia.

Peter Novodvorsky, Alan Bernjak, Ellen Downs

|Apr 23, 2024
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.

Peter Novodvorský, Lenka Thieme, Ivana Laňková

|Jul 08, 2023
Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia.

Mariana Rončáková, Arash Davani, Veronika Mikušová

|Oct 13, 2021
An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus.

Peter Novodvorský, Martin Haluzík

Pageof 2